$SHC News
Last published 1w ago
- 1w agoSHCSotera Health Co - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoSHCSotera Health Reports Solid Third-Quarter and Year-to-Date 2026 ResultsGlobeNewswireQ3 2026 net revenues increased 4.4% on both an as-reported and constant currency basis(1), compared to Q3 2025Q3 2026 net income of $58 million or $0.20 per diluted shareQ3 2026 Adjusted EBITDA(1) increased 3.9%, or
- 3w agoSHCSotera Health Announces Third-Quarter 2026 Earnings Release DateGlobeNewswireCLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare
- 2mo agoSHCWells Fargo 21st Annual Healthcare Conference - SOTERA HEALTH COEarnings Call TranscriptsGood afternoon, everyone. I am Rahul Sood, Managing Director in the Healthcare Investment Banking Group at Wells Fargo. On the stage, I'm joined by CEO of Sotera Health, Alton Scheher. Alton, welcome. Thank you. It's goo
- 3mo agoSHCSotera Health Q2 2026 Earnings Conference Call - SOTERA HEALTH COEarnings Call TranscriptsGood morning, and welcome to the Sotera Health Second Quarter 2026 Earnings Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key f
- 3mo agoSHCSotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 OutlookGlobeNewswireQ2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis(1) compared to Q2 2025Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted
- 3mo agoSHCSotera Health Announces Second-Quarter 2026 Earnings Release DateGlobeNewswireCLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare
- 6mo agoSHCSotera Health Announces Secondary Offering of Common StockGlobeNewswireCLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 31,838,253 shares of its common stock, par value
- 6mo agoSHCSotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 OutlookGlobeNewswireQ1 2026 net revenues increased 10.0%, or 6.5% on a constant currency basis, compared to Q1 2025Q1 2026 net income of $27 million or $0.09 per diluted share, compared to a net loss of $13 million or $0.05 per diluted
- 6mo agoSHCSotera Health Announces Leadership TransitionGlobeNewswireAlton Shader, CEO of Viant Medical®, to become CEO and join the Board of Directors, effective May 26, 2026Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Directors
- 6mo agoSHCSotera Health Announces First-Quarter 2026 Earnings Release DateGlobeNewswireCLEVELAND, April 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare
- 8mo agoROLSHCSotera Health Appoints Kenneth D. Krause to the Board of DirectorsGlobeNewswireCLEVELAND, March 16, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company" or "Sotera Health"), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and
- 8mo agoSHCSotera Health Announces Secondary Offering of Common StockGlobeNewswireCLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 25 million shares of its common stock, par value
- 8mo agoSHCSotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 OutlookGlobeNewswire2025 net revenues increased 5.7% to $1.164 billion, compared to 2024, or 5.2% on a constant currency basis2025 net income increased to $78 million or $0.27 per diluted share, compared to net income of $44 million, or
- 8mo agoSHCSotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release DateGlobeNewswireCLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare
- 9mo agoSHCSONTKRSotera Health Appoints Richard Kyle to the Board of DirectorsGlobeNewswireCLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare
- 10mo agoSHCSotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireCLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and
- 1y agoSHCSotera Health Announces Secondary Offering of Common StockGlobeNewswireCLEVELAND, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 30,000,000 shares of its common stock, par value
- 1y agoSHCSotera Health Reports Strong Third-Quarter and Year-to-Date 2025 ResultsGlobeNewswireQ3 2025 net revenues increased 9.1% to $311 million, or 8.0% on a constant currency basis(1), compared to Q3 2024Q3 2025 net income of $48 million, or $0.17 per diluted share, compared to net income of $17 million or
- 1y agoSHCSotera Health Announces Third-Quarter 2025 Earnings Release DateGlobeNewswireCLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare
- 1y agoSHCSotera Health Announces Secondary Offering of Common StockGlobeNewswireCLEVELAND, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 20,000,000 shares of its common stock, par value
- 1y agoSHCSotera Health Company (SHC) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSHCSotera Health Reports Strong Second-Quarter and First-Half 2025 ResultsGlobeNewswireQ2 2025 net revenues increased 6.4% to $294 million, or 6.0% on a constant currency basis(1), compared to Q2 2024Q2 2025 net income of $8 million or $0.03 per diluted share, compared to net income of $9 million or $0.03
- 1y agoSHCSotera Health Announces Second-Quarter 2025 Earnings Release DateGlobeNewswireCLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 1y agoSHCSotera Health Reports First-Quarter 2025 ResultsGlobeNewswireQ1 2025 net revenues increased 2.6% to $255 million, compared to Q1 2024, or 4.4% on a constant currency basisQ1 2025 net loss of $13 million or $0.05 per diluted share, compared to net income of $6 million or $0.02 per
- 1y agoSHCSotera Health Announces First-Quarter 2025 Earnings Release DateGlobeNewswireCLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the
- 1y agoSHCTYO:1223TYO:71Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility ResultsGlobeNewswireSALT LAKE CITY, March 04, 2025 (GLOBE NEWSWIRE) -- Nelson Labs, a Sotera Health company and a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and
- 1y agoSHCSotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 OutlookGlobeNewswire2024 net revenues increased 4.9% to $1.10 billion, compared to 2023; or 5.4% on a constant currency basis2024 net income of $44 million or $0.16 per diluted share, compared to 20232024 Adjusted EBITDA(1) increased 3.9%
- 1y agoSHCSotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release DateGlobeNewswireCLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 1y agoSHCSotera Health Chairman and CEO Presents at 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswireCLEVELAND, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and
- 1y agoSHCSotera Health to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswireCLEVELAND, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and
- 1y agoSHCSotera Health Company Appoints Vincent K. Petrella as Lead Independent DirectorGlobeNewswireCLEVELAND, Ohio, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the
- 1y agoSHCFirstlight Management Calls on the Board of Directors of Sotera Health Company to Launch Sale Process for Nelson LabsPR NewswireOn December 3, 2024, Firstlight Management LP sent a letter to the Board of Directors of Sotera Health Company (NASDAQ: SHC) calling for a sale of...
- 1y agoSHCSotera Health to Share Next Chapter of Growth at 2024 Investor DayGlobeNewswireCLEVELAND, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 2y agoSHCSotera Health Company (SHC) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSHCSotera Health Reports Third-Quarter and Year-to-Date 2024 ResultsGlobeNewswireQ3 2024 net revenues of $285 million increased 8.5%, compared to Q3 2023Q3 2024 net income of $17 million or $0.06 per diluted share, compared to net loss of $14 million or $0.05 per diluted share in Q3 2023 Q3 2024
- 2y agoSHCSotera Health Announces Dates for Third-Quarter 2024 Earnings Release and November 2024 Investor DayGlobeNewswireCLEVELAND, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 2y agoSHCSotera Health Announces Secondary Offering of Common StockGlobeNewswireCLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the launch of a secondary offering (the "Offering") of 25,000,000 shares of its common stock, par value
- 2y agoSHCSotera Health Company (SHC) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSHCSotera Health Reports Second-Quarter and First-Half 2024 ResultsGlobeNewswireQ2 2024 net revenues of $277 million increased 8%, compared to Q2 2023Q2 2024 net income of $9 million or $0.03 per diluted share, compared to net income of $24 million or $0.08 per diluted share in Q2 2023Q2 2024
- 2y agoHAESHCSotera Health Appoints Christopher Simon to the Board of DirectorsGlobeNewswireCLEVELAND, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 2y agoSHCSotera Health Announces Second-Quarter 2024 Earnings Release DateGlobeNewswireCLEVELAND, July 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare
- 2y agoSHCSotera Health Announces Closing of $1.5 Billion Term Loan B and $750 Million Senior Secured Note FinancingsGlobeNewswireCLEVELAND, May 30, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company ("Sotera Health" or the "Company") (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and
- 2y agoSHCSotera Health Company (SHC) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSHCSotera Health Reports First-Quarter 2024 ResultsGlobeNewswireQ1 2024 net revenues increased 12.5% to $248 million, compared to Q1 2023Q1 2024 net income of $6 million or $0.02 per diluted share, compared to net income of $3 million or $0.01 per diluted share in Q1 2023Q1 2024
- 2y agoSHCSotera Health Announces First-Quarter 2024 Earnings Release DateGlobeNewswireCLEVELAND, April 11, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the
- 2y agoSHCSotera Health Company (SHC) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoSHCSotera Health Announces Pricing of Secondary OfferingGlobeNewswireCLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (NASDAQ:SHC) (the "Company") today announced the pricing of its secondary offering (the "Offering") of 25,000,000 shares of its common stock, par value
- 2y agoSHCSotera Health Announces Secondary Offering of Common StockGlobeNewswireCLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (the "Company") today announced the launch of a secondary offering (the "Offering") of 25,000,000 shares of its common stock, par value $0.01 per
- 2y agoSHCSotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 OutlookGlobeNewswire2023 net revenues increased 4.5% to $1.05 billion, compared to 20222023 net income of $51 million or $0.18 per diluted share2023 Adjusted EBITDA(1) increased 4.3% to $528 million2023 Adjusted EPS(1) decreased $0.15 to